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ABSTRACT 
Transplastomic plants are a system of choice for the mass production of 
biopharmaceuticals due to the polyploidy of the plastid genome and the low risk of 
pollen-mediated outcrossing because of maternal inheritance. However, as field-grown 
plants, they can suffer contamination by agrochemicals and fertilizers, as well as 
fluctuations in yield due to climatic changes and infections. Tissue-type plasminogen 
activator (tPA), a protein used to treat heart attacks, converts plasminogen into 
plasmine, which digests fibrin and induces the dissolution of fibrin clots. Recently, we 
obtained transplastomic tobacco plants carrying the K2S gene encoding truncated 
human tPA (reteplase) with improved biological activity, and confirmed the presence of 
the target protein in the transgenic plant leaves. Considering the advantages of plant cell 
cultures for biopharmaceutical production, we established a cell line derived from the 
K2S tobacco plants. The active form of reteplase was quantified in cultures grown in 
light or darkness, with production 3-fold higher in light.  
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1. Introduction 
Biopharmaceuticals based on proteins, antibodies or nucleic acids are increasingly being 
used for disease treatment.  Although only about 60 peptides have been approved by the 
US FDA to date, more than 140 are under clinical study and by 2020 the global sales of 
biopharmaceuticals are expected to be worth over $US 278.2 billion (Santos et al., 
2016).  
Tissue type plasminogen activator (tPA), which induces the dissolution of fibrin clots 
by converting the zymogen plasminogen into the serine protease plasmin, is a clinically 
useful thrombolytic agent (Clark, 2001) and a target for biotechnological production. 
tPA has five domains, N terminal finger, epidermal growth factor, serine protease, 
Kringle 1 and Kringle 2 (Youchung et al., 2003). The active part of tPA, the 
thrombolytic Kringle 2 domain, serine protease domain, two functional regions of 
proteasa (176-527 amino acid residues), plus the 1 to 3 amino acids of the N-terminal is 
known as the truncated human tissue plasminogen activator (K2S, reteplase), which has 
a longer plasma half-life and higher fibrinolytic activity than tPA (Nordt and Bode, 
2003). 
The main biotechnological systems for the production of recombinant 
biopharmaceuticals are based on microorganism cultures such as Escherichia coli and 
yeast at bioreactor level, while large proteins are generally produced by mammalian cell 
platforms (Demain and Vaishnav, 2009). Molecular farming also has been utilized for 
biopharmaceutical production, because transgenic plants only need water, minerals and 
sunlight for growth, but a drawback of the system, according to the US Agricultural 
Department, is a lack of guaranteed transgene contention and the risk of contamination 
of the human food chain if edible plant species are used as the host (Wilson and 
Roberts, 2012). Moreover, transgenic crops used for the production of heterologous 
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proteins are exposed to agrochemicals and fertilizers in the field, while variable culture 
conditions and the impact of bacterial and fungal infections can lead to fluctuations in 
yield (Hellwig et al., 2004). 
As an alternative production system, plant cell cultures share the capacity of transgenic 
crops for proper protein folding and can assemble complex recombinant proteins. They 
also have similar advantages to bioreactor systems based on microorganisms and 
mammalian cells, as they avoid transgene dissemination and provide controlled and 
sterile growth conditions, chemically defined culture media, and compliance with 
pharmaceutical good manufacturing practices, ensuring the biosafety and productivity 
of the system (Demain and Vaishnav, 2009; Santos et al., 2016). Furthermore, they 
allow proteins to be manufactured in days or weeks, rather than the months or years 
required when depending on the growth cycle of a whole plant (Doran, 2000).  
Several factors affecting transgenic crops, such as climate, soil quality, season, day 
length and weather, are not issues for biotechnological platforms based on plant cell 
cultures. Additionally, the secretion of heterologous proteins into the culture medium 
simplifies downstream processing and protein purification (Pham et al., 2012). The first 
human recombinant protein approved in the US and other countries was Taliglucerase 
alfa, a modified glucocerebrosidase enzyme used to treat Gaucher’s disease, produced 
by Protalix Biotherapeutics in the ProCellEx® platform based on carrot cell cultures 
(Tekoah et al., 2015).  
Transplastomic plants have been targeted for the production of biopharmaceuticals due 
to the high number (approx. 100) of chloroplasts per plant cell, the high copy number  
(approx. 10000) of the plastid genome, as well as the maternal mode inheritance, though 
low-level leakages of transgenes in pollen may occur (Bock, 2014). Transplastomic 
technology has enhanced field-grown plant resistance to herbicides and plagues and has 
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been used for the production of recombinant proteins. However, the derived cell 
cultures have been scarcely applied for the biotechnological production of heterologous 
proteins (Block, 2007). Examples of biopharmaceuticals produced in transplastomic 
tobacco plant cell cultures include the phage-derived endolysins, used as an antibiotic 
against pneumonia (Oey et al., 2009), camelid antibodies (Lentz et al., 2012), the 
transforming growth factor (TGFβ3), a cytokine-type protein (Gisby et al., 2011), and 
fragment C of tetanus toxin (TetC). The latter was accumulated up to 7 mg/L, but when 
the transplastomic cell suspension was cultured in a temporary immersion bioreactor 
(TIB), regenerated shoots achieved a TetC production of 95 mg/L (Michoux et al., 
2011).  
Recently, our group obtained tobacco transplastomic plants harboring the K2S gene  
driven by the promotor Prrn for the production of the truncated human tissue 
plasminogen activator (K2S, reteplase), which is one of the most important 
pharmaceutical recombinant proteins, widely used to break down blood clots through 
the conversion of plasminogen to plasmin (Abdoli-Nasab et al., 2013). The purification 
system of reteplase has been recently optimized, reaching a production of up to 30.6 
µg/100 mg fresh weight of leaf tissue (Abdoli-Nasab et al., 2016). Taking into account 
the potential advantages of plant cell cultures for the production of biopharmaceuticals, 
in this work we demonstrate for the first time the capacity of cell suspension cultures 
derived from K2S transplastomic tobacco plants to produce the bioactive target peptide.  
 
2. Material and Methods 
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2. 1. Plant material 
In this work, we utilized seeds from homoplastic plants carrying the K2S gene driven by 
the promotor Prrn obtained as described by Abdoli-Nasab et al. (2013). Sterile seeds 
were germinated on solidified MS (Murashige and Skoog, 1962) medium supplemented 
with 500 mg/L spectinomycin, in Magenta vessels (SIGMA). The in vitro plantlets were 
cultivated in a climate chamber at 25ºC under a 16 h photoperiod and an approximate 
light intensity of 60 µmol m-2 s-1. 
2.2. Initiation and maintenance of the transgenic cell suspension  
Leaf discs of young K2S plants were cultivated in darkness or under light conditions for 
callus induction in solid MS medium (Murashige and Skoog, 1962) supplemented with 
2.14 mg/L of naphthalene acetic acid in combination with 0.215 mg/L of kinetin (Piñol 
et al., 1985) and 500 mg/L of spectinomycin (Fig. 1). After several subcultures, 30 g of 
friable calli were placed in 300 mL of liquid MS medium with the same hormones and 
antibiotic to obtain a fine cell suspension, which was subcultured every 12 days, shaken 
at 115 rpm and maintained at 25 °C in darkness or light conditions. 
2.3. qPCR analysis 
Expression of the K2S gene in the cell suspension was verified by qPCR. The 
elongation factor 1 α (EF-1 α) as the nuclear-encoded reference (Schmidt et al., 2010) 
and the accD-like plastid-encoded (Lee et al., 2004) were used for gene normalization. 
The stability of the housekeeping gene expression was analyzed by calculating the 
coefficient of variation (CV), as previously described (Exposito-Rodriguez et al., 2008). 
Total RNA from the plant material was isolated with TRIzol reagent (Invitrogen, 
Carlsbad, CA). For the qRT-PCR, cDNA was prepared from RNA treated with DNase I 
(Invitrogen, Carlsbad, CA) and synthesized with SuperScript IV reverse transcriptase 
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(Invitrogen, Carlsbad, CA). qRT-PCR was performed using the iTAqTM universal 
SYBR Green Supermix (BioRad, Hercules, CA, EEUU) in a 384-well platform system 
(LightCycler_480 Instrument; Roche), and each sample was run in triplicate, under the 
following conditions: 95 °C for 2 min, 40 cycles (95 °C, 10 s; 60 °C, 20 s; 72 °C, 20 s) 
followed by a melting curve. Gene-specific primers were designed with Primer-BLAST 
(Table 1).  
2.4. Protein extraction  
Total soluble protein (TSP) was extracted as described by Wang et al. (2005) with slight 
modifications. Briefly, 4 g of the harvested cell suspension was ground in liquid 
nitrogen and placed in a 15 mL tube, which was filled with 10% trichloroacetic acid / 
acetone, and centrifuged at 10000 g for 5 min (4°C). The supernatant was removed, 
washed with 0.1 M ammonium acetate / 80% methanol and centrifuged. The pellet was 
washed with 80% acetone, and air-dried at room temperature for 10 min. The tube with 
the pellet  was filled with phenol/SDS buffer (Wang et al., 2005), mixed thoroughly and 
incubated for 5 min on ice. After centrifugation, the upper phase was recovered in a new 
tube, which was filled with 0.1 M ammonium acetate / 80% methanol, incubated over 
night at -20°C and then centrifuged at 10000 g for 10 min (4°C). Finally, the pellet was 
washed once with 100% methanol and once with 80% acetone and air-dried. The 
protein was resuspended in 6 M urea and quantified using the RC DC Protein Assay Kit 
II (Bio-Rad, CA, USA). 
Native proteins were extracted using finely ground powder under liquid nitrogen. Per 5 
g of cells, 10 mL of cold buffer solution was used (buffer: 250 mM sucrose, 50 mM 
HEPES, 5% glycerol, 10 mM Na2O5S2, 1% PVP, 10 mM ascorbic acid and 100 mM 
PMSF, pH=7.5). The mixture was thoroughly homogenized and centrifuged at 12000 g 
for 15 min (4°C). Finally, the supernatant was purified for further analysis.  
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2.5. Protein purification 
For purification of the recombinant protein, a His GravitrapTM TALON® (GE 
HealthcareBio-Sciences AB, Uppsala, Sweden) was used following the manufacturer’s 
instruction. The eluted protein was concentrated by Amicon® Ultra-2 (30K) Centrifugal 
Filter Devices (Millipore Corp., Bedford, MA), and the buffer exchange was carried out 
with buffer phosphate (50 mM sodium phosphate, 300mM NaCl, pH=7.4). Finally, the 
quantification was done by the RC DC Protein Assay Kit II (Bio-Rad, CA, USA). 
2.6. SDS-PAGE and sample preparation for mass spectrometry analysis 
The TSP extracted from the cell suspension was placed (100 µg) in 12% acrylamide gel 
followed by staining with Coomassie brilliant blue (Laemmli, 1970). The gel bands 
located at 48 kDa were processed as described by Gundry et al. (2010). For digestion, 
sequencing grade modified trypsin (V5111, Promega, Madison, WI) was used and 
samples desalted with PepClean™ C-18 Spin Columns (Thermo Fisher Scientific, 
Rockford, IL) according to the manufacturer’s recommendations. 
2.7. Liquid chromatography-mass spectrometry 
For protein identification, MS and MS/MS data were acquired in an Agilent XCT plus 
ion trap mass spectrometer with a ChipCube interface fed by an Agilent 1100 series 
nanopump HPLC system (Martínez-Esteso et al., 2011). The four most intense 
precursor ions in the MS scans were selected for MS/MS and then passed to an active 
exclusion list released after 1min. Raw data were converted into a peak list with the 
extraction tool of SpectrumMill Proteomics Workbench (SMPW) (Agilent). The 
reduced data set was searched against the Swissprot forward and reversed protein 
database without taxonomical restrictions in the identity mode with the MS/MS search 
tool of SpectrumMill Proteomics Workbench, using the following parameters: trypsin, 
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up to 1 missed cleavages, fixed modification carbamidomethylation of cystein, the 
variable modification oxidation of methionine, and a mass tolerance of 2.5 Da for the 
precursor and 0.7 Da for product ions. Peptide hits were validated first in the peptide 
mode and then in the protein mode according to the score settings recommended by the 
manufacturer. 
The MRM selector tool of SMPW was used to generate transition lists from validated 
peptide identifications by selecting the five most intense precursor/product ion pairs for 
each target peptide above the precursor m/z, and calculating the collision energy for 
each precursor ion. 
The MRM experiments were performed on an Agilent’s standard flow LC-MRM-MS 
platform (Agilent Technologies, Palo Alto, CA) consisting of a 1290 Infinity UHPLC 
interfaced to a 6490 triple quadrupole mass spectrometer via a JetStream ESI source. 
Protein sample digests were separated using an Advance Bio Peptide Map 2.1*150mm 
2.7 µm column thermostated at 50ºC at 0.4 mL/min flow rate over a 6-min run along a 
linear gradient from 0 to 70 % of solvent B consisting of 0.1% FA in 90% ACN. Source 
parameters were: 3000-3500 V capillary voltage, 15 L/min N2 gas flow, 150ºC gas 
temperature. Each transition was acquired at unit resolution in standard mode for 10ms 
dwell time at 3 duty cycles per second. 
A project was created in the open source application Skyline (MacLean et al., 2010) 
using the sequence of identified peptides and selecting manually the previously 
generated transitions, in order to import, visualize, refine the acquisition method and 
compare the LC-MRM runs. 
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2.8. Activity assay 
The protein assay was performed with a tissue-type plasminogen activator (tPA) Human 
Chromogenic Activity Assay Kit (ab108905, abcam, Cambridge, UK). This assay 
measures the ability of tPA to activate the plasminogen to plasmin. The amount of 
plasmin produced is quantitated using a specific substrate releasing a yellow p-
nitroaniline chromophore. Briefly, human plasminogen, plasmin substrate and tPA 
standard were prepared following the manufacturer’s instructions. Then, a standard 
curve was prepared in triplicate by serial dilution, considering 7 points (40, 10, 2.5, 
0.625, 0.156, 0.039 and 0 IU mL-1). Next, a mixture of specific diluent, plasminogen 
and plasmid substrate (60, 10 and 10 µL respectively) was distributed in a 96-well 
microplate. Finally, 20 µL of standard points or samples were added, incubated at 37 °C 
and the absorbance was periodically read at 405 nm for up to 9 h, according to the 
manufacturer’s recommendation.      
 
3. Results and Discussion  
3.1 Establishment of transgenic cell suspension cultures and K2S gene expression.  
After 2 months of the initial callus induction, sufficient material was obtained to 
establish the cell suspension. A characteristic green color was observed in the callus and 
cell suspension grown in light (Fig. 1 A, B). After 12 days of culture, samples from the 
cell suspension growing in light or darkness were taken for the planned analyses. Their 
growth capacity was measured as a growth index (harvested fresh weight / inoculum 
fresh weight, GI) and biomass productivity (rx). Light was found not to affect the 
biomass production of the system, and in both conditions, the cell cultures reached a GI 
> 3, which represents a rx > 18.5 g L-1d-1 (Fig. 2), a growth capacity very similar to the 
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untransformed tobacco cell lines (data not shown). These results show the high capacity 
of the system based on tobacco suspension cultures to produce biomass, which was not 
affected by the K2S gene expression. Similar results for growth capacity were reported 
previously for tobacco cell cultures genetically designed for the heterologous production 
of the t-resveratrol derivative, t-piceatannol (Hidalgo et al., 2017), and for the 
production of scopolamine in transgenic tobacco cell lines carrying the HnH6H gene 
(Moyano et al., 2007). 
In order to normalize the gene expression data more precisely in the qPCR analyses, cp 
values of housekeeping genes (EF1 and accD) were used, in combination or separately, 
to calculate and compare the CV between them, as described in Material and Methods. 
The results, CVEF1= 0.0247 < CVEF1&accD= 0.0307 < CVaccD = 0.0513, demonstrated that 
the accD gene expression was affected by light and was therefore not useful for this 
experiment, while EF1 proved more stable under both conditions, giving the smallest 
CV value, which indicates less variability than shown by the combination of EF1 and 
accD or accD (Table 2 and Figure 1 C).   
In contrast with the growth capacity, the analysis of the K2S gene expression showed 
significant differences according to the conditions, with 4.6-fold higher gene expression 
when the cell line was cultured under light. These results could be related to the green 
color of this cell suspension, which is probably caused by a higher degree of chloroplast 
organization and/or their number per cell. Recently, Barreto et al. (2017) developed 
transgenic calli for the heterologous production of the fragment C of tetanus toxin 
(TetC), and reported a positive correlation between green shoot development and TetC 
yield when the callus was cultivated in a temporary immersion culture. 
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3.2 Characterization of rtPA heterologous protein by Mass Spectrometry  
The acrylamide gel bands corresponding to the predicted molecular weight of the K2S 
protein were successfully submitted to qualitative analysis. A method was previously 
established to detect 7 different reteplase peptides, 3 of which were proteotypic (Fig. 3), 
i.e. they were exclusive to reteplase and with no homology with related species (Fig.4). 
Each peptide was detected with at least 3 transitions, which gives specificity to the 
analysis. In all the samples from transgenic material overexpressing the K2S gene, 
peptides associated with reteplase were found and as expected, the signals were not 
detected in the wild type cell suspension. In all samples, the most intensive signals were 
detected for the peptides GGLFADIASHPWQAAIFAK and VYTAQNPSAQALGLGK 
(Fig. 5 A), at a retention time of 3.4 min and 2.0 min respectively (Fig. 5 B). The 
transitions of the peptide GGLFADIASHPWQAAIFAK were detected both in samples 
kept in the dark and in light without significant quantitative differences probably 
because the transitions for this peptide give rise to many unspecific signals in the 
tobacco proteome background. Transitions of the peptide VYTAQNPSAQALGLGK 
were well above noise in light treated samples while only noise could be detected in 
darkness treated samples. The later is consistent with the higher plastid abundance and 
the K2S expression levels in light conditions, thus validating the suitability monitoring 
VYTAQNPSAQALGLGK by MRM as a surrogate peptide of K2S. The results 
confirmed the capacity of the K2S transgenic cell line to biosynthesize the target 
biopharmaceutical.  
3.3 Determination of the protein content and activity assay.  
As the reteplase was polyhistidine-tagged (Abdoli et al. 2013), the recombinant protein 
expressed in chloroplasts was estimated by measuring the TSP before purification and 
after concentration of the eluted protein from the column, as described in Material and 
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Methods. The rtPA content reached in the tobacco cell suspension when cultivated in 
darkness was 0.083 % of the TSP, rising to 0.277% in light conditions, which represents 
an increase of more than 3-fold. These results are consistent with the MRM signal 
intensities for the peptide VYTAQNPSAQALGLGK and the production values were 
lower than those obtained in the transplantomic mother plant (approx. 1% of TSP) 
(Abdoli Nasab et al., 2016), but in that case the protein was harvested after 8 weeks 
rather than the 2 weeks of the cell suspension culture period. In accordance with 
previous reports (Michoux et al., 2011; Hong et al., 2002; Hellwig et al., 2004; 
Magnuson et al., 1998), this result shows that the production of recombinant protein in 
plant cell suspensions is lower than in the whole plant.  
The plastid genome contains many promoters (Liere and Maliga, 2001), but the strong 
sigma70-type rRNA operon (Prrn) promoter, which is well-recognized by the plastid-
encoded plastid RNA polymerase, is commonly used for plastid transformation (Maliga, 
2004). Prrn, a constitutive promoter in chloroplasts and prokaryotes, is reported to cause 
high levels of transcript accumulation in plastids of plants, but it has been described as 
having low activity in plant cell suspensions (Michoux et al., 2011). Other factors might 
also be responsible for lower reteplase production in the obtained cell cultures, such as 
less differentiated cells and plastids (Michoux et al., 2013), instability of the 
recombinant protein secreted to the medium due to protease release from disrupted cells 
(Hong et al., 2002), or aggregation occurring when the daughter cells do not separate in 
the cell division (Santos et al., 2016). Nevertheless, the rtPA yield was significantly 
higher than the tPA production (up to 0.017%) in a hairy root system (Kang et al., 
2011). 
Unlike tPA, reteplase has no carbohydrate side chains and thus can be produced in E. 
coli cells, but  most of the protein is present as an inclusion body, making its extraction 
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and renaturation a time-consuming downstream process, involving solubilization and 
protein refolding and dialysis (Khodabakhsh et al., 2013). In contrast, as the target 
protein in our biotechnological system was tagged with 6-his, it was easily purified 
using a column containing  TALON-Superflow® medium precharged with cobalts ions, 
and the active K2S protein was recovered according to the method previously developed 
by Abbdoli Nasab et al. (2016). 
For the quantitative measurement of reteplase activity, the extracted native protein was 
obtained from a cell suspension growing in light, since the production was higher than 
in darkness. The crude extract was purified and concentrated as described in Material 
and Methods, and the use of the Plasminogen Activator Human Chromogenic Activity 
Assay Kit allowed activity against plasminogen to be measured throughout 9 h of 
incubation at 37°C. The behavior of the extracted enzyme (1460 µg) was comparable to 
the 2.5 UI mL-1 tPA standard curve (Fig. 6).  
Further approaches to enhance the productivity of the K2S tobacco cell suspensions 
could be based on modifying the promoter and vector regulatory elements (Hong et al., 
2002). Adding signal peptides like 33KDsp may improve secretion efficiency (Haung et 
al., 2015), minimize processing time and avoid proteolytic and oxidative degradation of 
recombinant proteins (Fischer, 1999). Fusion tags including fungal hydrophobin (Reuter 
et al., 2014) or zein-derived peptides could increase the protein accumulation (Joseph et 
al., 2012). The culture medium could be optimized, e.g. by increasing aeration (Liu and 
lee, 1999) or adding growth medium supplements such as amino acids (Fischer et al., 
1999), gibberellic acid, haemin (Tsoi and Doran, 2002), a carbon source (Santos et al., 
2016), protease substrates like gelatin, biopolymers (Lee et al., 2002, Kwon et al., 2002) 
or  bovine serum albumin (James et al., 2000; Baur et al., 2005). The results obtained 
demonstrate that the extraction of reteplase in native conditions preserves its biological 
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activity and the biotechnological system could be successfully used for the production 
of this biopharmaceutical.  
 
4. Conclusions 
In this study we developed tobacco cell cultures derived from transgenic K2S plants for 
the viable production of the biopharmaceutical reteplase. Although the risk of transgene 
dispersion in transplastomic plants is low due to the maternal mode inheritance, the cell 
culture system guarantees transgene containment. Also, like other bioreactor systems, 
the target compounds can be produced under strictly controlled culture conditions, thus 
avoiding the risk of contamination with human pathogens associated with mammalian 
cells; it also has the capacity for proper protein folding. We have demonstrated the 
capacity of the transplastomic K2S cell cultures to produce active reteplase and the 
enhancing effects of light on its production, achieving a TSP content of 0.277 % after a 
2-week growth period. These results open a new avenue for the production of reteplase 
in transplastomic plant cell cultures as an alternative bio-sustainable system for 
biopharmaceutical production. 
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Table 1. Sequences of the primers used to amplify the genes by qPCR 
Gene Primer Sequence Amplicon 
size bp Reference 
Elongation 
factor 
(EF1) 
FW: TGGTCAGGAGATTGCGAAAGAGC 
RV: ACGCAAAACGCTCCAATGGTG  
130 Hidalgo et 
al. (2007) 
accD 
FW ACAACTGGTGGAGTGACAGC  
RV ATGCAATGTAGGCGTTGGGT  
76 This work 
K2S 
FW: GCATGACTTTGGTGGGCATC  
RV: CGGGACATCCTTCTGTCCAC 
59 This work 
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Table 2. Evaluation of housekeeping stability by CV 
Mean Cp 
Housekeeping EF1 EF1&accD accD 
Light 
26.974232 21.374679 15.775127 
28.009782 22.110455 16.211128 
27.866260 21.834132 15.802004 
Darkness 
27.315741 22.310272 17.304803 
28.948752 23.314494 17.680236 
28.130729 22.747606 17.364483 
Mean 27.874249 22.281940 16.689630 
SD 0.687129 0.683648 0.856542 
CV 0.0247 0.0307 0.0513 
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Figure legends: 
Figure 1. Appearance of the callus cultures (A) and the derived cell suspensions (B) 
growing under dark and light conditions. (C) Analysis of the relative K2S gene 
expression normalized to Elongation Factor 1α. 
Figure 2. A) Growth capacity of the cell suspension measured as growth index (GI) and 
biomass productivity (rx) and B) reteplase production of the cell suspensions growing 
under dark and light conditions. TSP, total soluble protein. Each value is the average of 
3 biological replicates ± SE.  
Figure 3. Mass spectrum and fragment ion of the 3 proteotypic peptides for the human 
tPA protein. 
Figure 4. Multiple sequence alignment of tPA in related species. Those that are 
highlighted represent the seven peptides for method detections and those that are framed 
correspond to proteotypic peptides for human tPA (protein ID P00750). 
Figure 5. Peptide characterization. (A) Identification of the most intensive peptides in 
cell cultures under dark and light conditions. (B) Chromatogram, indicating specific 
retention time and intensity of each fragment ion.     
Figure 6. Quantitative determination of the native reteplase protein activity, extracted 
from the K2S cell suspension measured with Tissue type Plasminogen Activator Human 
Chromogenic Activity Assay Kit. 
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Highlights: 
Reteplase was produced in cell cultures derived from K2S transplastomic tobacco plants.   
Heterologous rtPA protein was successfully characterized by mass spectrometry.   
Purified native reteplase showed activity against plasminogen. 
Reteplase production in the K2S cell cultures was enhanced by light. 
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